J Shimada
About
In The Last Decade
J Shimada
31 papers receiving 554 citations
Peers
Comparison fields: 5 of 82
- Pharmacology 260
- Epidemiology 222
- Public Health, Environmental and Occupational Health 154
- Molecular Biology 111
- Molecular Medicine 103
Countries citing papers authored by J Shimada
This map shows the geographic impact of J Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Shimada more than expected).
Fields of papers citing papers by J Shimada
This network shows the impact of papers produced by J Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Shimada. The network helps show where J Shimada may publish in the future.
Co-authorship network of co-authors of J Shimada
This figure shows the co-authorship network connecting the top 25 collaborators of J Shimada. A scholar is included among the top collaborators of J Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Shimada. J Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 8 | |
| 4 | 20 | |
| 5 | 27 | |
| 6 | 21 | |
| 7 | 148 | |
| 8 | [Case of melioidosis associated with acute empyema and cellulitis of the leg]. | 3 |
| 9 | [Neurotoxicity of antibacterial agents (tetracyclines, chloramphenicol, aminoglycosides, beta-lactams and others)]. | 1 |
| 10 | [Antimicrobial activities of roxithromycin against recently obtained clinical isolates]. | 1 |
| 11 | [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens]. | 1 |
| 12 | 2 | |
| 13 | 8 | |
| 14 | Aptameric inhibition of in vitro DNA polymerization by phosphorothioate oligonucleotides. | 1 |
| 15 | Overview of a new carbapenem, panipenem/betamipron. | 17 |
| 16 | A comparative study on the convulsant activity of carbapenems and beta-lactams. | 33 |
| 17 | 38 | |
| 18 | 40 | |
| 19 | [Studies of isolated organisms from otorhinolaryngological infections and their susceptibilities to macrolide antibiotics]. | 1 |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.